Nordicus Partners Corporation Uplists to OTCQB
Nordicus Partners (OTCQB: NORD) has announced its uplisting to the OTCQB, a recognized public securities market by the SEC. This move aims to enhance liquidity, achieve fair valuation, and attract a wider network of investors and media partners. The uplisting is expected to aid in executing growth plans and making shares more appealing to potential targets.
Nordicus Partners has successfully uplisted to the OTCQB, a move that is recognized by the SEC as an established public securities market.
The uplisting to OTCQB aims to build shareholder value, enhance liquidity, achieve fair valuation, and engage a greater network of investors, data distributors, and media partners.
The uplisting will help execute growth plans, making shares more attractive to potential acquisition and recruiting targets.
- None.
Beverly Hills, California., May 09, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic and U.S. Life Sciences companies with optimal conditions to establish themselves on the U.S. market, today announced that it has uplisted to the OTCQB. OTCQB is recognized by the SEC as an established public securities market. OTCQB companies must provide current company financial information/news and meet financial standards that enable brokers to more easily quote and trade a security.
Henrik Rouf, CEO of Nordicus, stated, “We are pleased to announce our uplisting to the OTCQB, which should enable Nordicus to build shareholder value with the goals of enhancing liquidity and achieving fair valuation. It should also allow Nordicus to engage a greater network of investors, data distributors, and media partners, ensuring better access to high-quality information. The uplisting will also help us execute our growth plans by making our shares more appealing to both acquisition and recruiting targets.
About Nordicus Partners Corporation
Nordicus Partners Corporation and its Denmark-based financial consulting company, specializing in providing Nordic and U.S. Life Sciences companies with the best possible conditions to establish themselves on the U.S. market, taking advantage of management’s combined +90 years of experience in the corporate sector, serving in different capacities both domestically and globally. The company’s core competencies lie in assisting Danish as well as other Nordic and international companies in different areas of corporate finance activities, such as: business valuations, growth strategies, attracting capital for businesses and company acquisitions and sales. For more information about Nordicus, please visit: www.nordicuspartners.com
Forward-Looking Statements
The Company believes that this press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Terms such as “may,” “might,” “would,” “should,” “could,” “project,” “estimate,” “pro-forma,” “predict,” “potential,” “strategy,” “anticipate,” “attempt,” “develop,” “plan,” “help,” “believe,” “continue,” “intend,” “expect,” “future,” and terms of similar import (including the negative of any of these terms) may identify forward-looking statements. Such forward-looking statements, including but not limited to statements regarding the plans and objectives of management for future operations, are based on management’s current expectations and are subject to risks and uncertainties that could cause results to differ materially from the forward-looking statements. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Factors that may influence or contribute to the accuracy of the forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, market acceptance of the company’s products and services; competition from existing products or new products that may emerge; the implementation of the company’s business model and strategic plans for its business and our products; estimates of the company’s future revenue, expenses, capital requirements and need for financing; current and future government regulations; and developments relating to the company’s competitors. Readers are cautioned not to place undue reliance on forward-looking statements because of the risks and uncertainties related to them. For further information on such risks and uncertainties, you are encouraged to review the Company’s filings with the Securities and Exchange Commission (“SEC”), including its Current Report on Form 8-K relating to the reverse acquisition and related transactions which was filed with the SEC on March 1, 2023 and its quarterly report on Form 10-Q for the fiscal period ended December 31, 2023. The Company assumes no obligation to update any forward-looking statements as a result of new information or future events or developments, except as required by law.
For further information contact:
Mr. Henrik Rouf
Chief Executive Officer
Phone +1 310 666.0750
Email hr@nordicuspartners.com
FAQ
What is the stock symbol for Nordicus Partners ?
What is the significance of uplisting to the OTCQB for Nordicus Partners ?
What are the core competencies of Nordicus Partners ?
